ACT 40th Annual Meeting
We’re excited to have Dr. Scott E. Boley co-chair two CE courses this year and Dr. Jeffrey Klein present the session “What to Know When Choosing a Model for Dermal Research” at the meeting. We hope can join us!
“What to Know When Choosing a Model for Dermal Research”
Presented by Dr. Jeffrey Klein, PhD, DABT
Wednesday, November 20, 2019
Session #2: 8:00am-8:55am
The minipig is considered to be the best animal model to understand drug effects in human skin. The Hanford and Göttingen minipigs have been used for accepted regulatory submissions. Sinclair Research is developing a white Sinclair lineage, which may provide another alternative when choosing a model for dermal research.
Participants in this program will learn about the use of minipigs for development of dermal products. Differences between lineages of minipigs will be discussed, including the pros and cons of each lineage. In addition, Sinclair will present recent results comparing irritation, clinical pathology, and histopathology from different minipigs.
| Guy Bouchard | CEO |
| Scott Boley | Vice President,Research & Operations |
| Jeff Klein | Director, Toxicology & Dermatology |
| Luke Zhang | Senior Scientist |
| Robyn Harvey | Scientist I |
| Andy Brown | Vice President, Commercial Operations |
| Greg Ochs | Senior Director, Business Development |
| Bob Neiswender | Director, Business Development |
| Eric Blair | Director, Business Development |
| Jyoti Mundra | Director, Business Development |
| George Kerrick | Director of Marketing |
JW Marriott Desert Ridge
5350 E Marriott Dr
Phoenix, AZ 85054
Booth #406
Platinum Annual Meeting Sponsor
